Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Excision BioTherapeutics
What AI says about Excision BioTherapeutics
Excision BioTherapeutics is a biotechnology company focused on developing innovative CRISPR-based therapies aimed at curing viral infectious diseases. Their mission is to improve the lives of chronically ill patients by excising viral genomes from infected individuals.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
CRISPR-based Therapies
Therapies targeting viral infectious diseases such as HIV, Herpes simplex viruses, and Hepatitis B.
Common Questions
What diseases does Excision BioTherapeutics target?
Excision BioTherapeutics targets viral infectious diseases including HIV, Herpes simplex viruses (HSV 1&2), and Hepatitis B.
What technology does Excision use for its therapies?
Excision uses proprietary CRISPR-based gene-editing technology licensed from leading research institutions.
Where is Excision BioTherapeutics located?
Excision BioTherapeutics is located in Watertown, MA.
When was Excision BioTherapeutics founded?
Excision BioTherapeutics was founded in 2015.
What is the aim of Excision's therapies?
The aim of Excision's therapies is to improve the lives of chronically ill patients by excising viral genomes from infected individuals.